Cargando…

Case study of a critically ill person with COVID-19 on ECMO successfully treated with leronlimab

The number of confirmed cases of infection with SARS-CoV-2, the virus causing Coronavirus disease 2019 (COVID-19), continues to increase and is associated with substantial morbidity and mortality in virtually every country in the world. Although in the long-term mass vaccinations remains the most pr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Elneil, Sohier, Lalezari, Jacob P., Pourhassan, Nader Z.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Case report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7985604/ https://www.ncbi.nlm.nih.gov/pubmed/33778462 http://dx.doi.org/10.1016/j.jtauto.2021.100097

Ejemplares similares

Disruption of CCR5 signaling to treat COVID-19-associated cytokine storm: Case series of four critically ill patients treated with leronlimab
por: Agresti, Nicholas, et al.
Publicado: (2021)

LERONLIMAB AND THE ROLE OF CCR5 SUPRESSION IN COVID-19 TREATMENT
por: BJORK, SARAH, et al.
Publicado: (2021)

Suppression of human and simian immunodeficiency virus replication with the CCR5-specific antibody Leronlimab in two species
por: Chang, Xiao L., et al.
Publicado: (2022)

ECMO for Critically Ill COVID-19 with ARDS: A Case Series
por: Rai, D., et al.
Publicado: (2021)

Extracorporeal hemoadsorption in critically ill COVID-19 patients on VV ECMO: the CytoSorb therapy in COVID-19 (CTC) registry
por: Hayanga, J. W. Awori, et al.
Publicado: (2023)

CCR5 Receptor Occupancy Analysis Reveals Increased Peripheral Blood CCR5+CD4+ T Cells Following Treatment With the Anti-CCR5 Antibody Leronlimab
por: Chang, Xiao L., et al.
Publicado: (2021)

Clinical Characteristics and Outcomes of Coronavirus Disease 2019 Patients Who Received Compassionate-Use Leronlimab
por: Yang, Bryant, et al.
Publicado: (2020)

Extracorporeal endotoxin adsorbent therapy in the critically ill patients with COVID-19 during ECMO
por: Fu, Bao, et al.
Publicado: (2023)

Extracorporeal endotoxin adsorbent therapy in the critically ill patients with COVID-19 during ECMO
por: Fu, Bao, et al.
Publicado: (2023)

The role of ECMO in COVID‐19: Can it provide rescue therapy in those who are critically ill?
por: Savarimuthu, Sugeevan, et al.
Publicado: (2020)

Bleeding Complications in COVID-19 Critically Ill ARDS Patients Receiving VV-ECMO Therapy
por: Flinspach, Armin Niklas, et al.
Publicado: (2023)

Demand and capacity to integrate pelvic organ prolapse and genital fistula services in low-resource settings
por: Tripathi, Vandana, et al.
Publicado: (2018)

Cytokine Adsorption in Critically Ill Patients Requiring ECMO Support
por: Lother, Achim, et al.
Publicado: (2019)

ARDS from miliary tuberculosis successfully treated with ECMO
por: Vesteinsdottir, Edda, et al.
Publicado: (2019)

Critically ill patients with COVID-19 with ECMO and artificial liver plasma exchange: A retrospective study
por: Liu, Jian, et al.
Publicado: (2020)

Comment on: Extracorporeal hemoadsorption in critically ill COVID‑19 patients on VV ECMO: the CytoSorb therapy in COVID‑19 (CTC) registry
por: Supady, A., et al.
Publicado: (2023)

Continuous venous hemodialysis integrated to the ECMO circuit in critically ill patient with COVID-19, a case report in Morocco
por: Mounir, Anass, et al.
Publicado: (2020)

Pheochromocytoma Crisis Presenting With ARDS Successfully Treated With ECMO-Assisted Adrenalectomy
por: Choudhary, Manita, et al.
Publicado: (2021)

Successful Urgent TAVI for Critical Aortic Valve Stenosis after ECMO Implantation
por: Niu, Ya-Lei, et al.
Publicado: (2022)

Prevalence of acute neurological complications and pathological neuroimaging findings in critically ill COVID-19 patients with and without VV-ECMO treatment
por: Ippolito, Angelo, et al.
Publicado: (2022)

ECMO/CRRT combined support in the treatment of critically ill patients with novel coronavirus pneumonia
por: Zou, Hai, et al.
Publicado: (2020)

Therapy and Outcome of Prolonged Veno-Venous ECMO Therapy of Critically Ill ARDS Patients
por: Flinspach, Armin N., et al.
Publicado: (2023)

Successful Use of Argatroban to Treat a Critically Ill Patient with Coagulopathy and Nephropathy Secondary to COVID-19
por: Frise, Matthew C., et al.
Publicado: (2020)

Prognosis when using extracorporeal membrane oxygenation (ECMO) for critically ill COVID-19 patients in China: a retrospective case series
por: Zeng, Yingchun, et al.
Publicado: (2020)

Leronlimab, a humanized monoclonal antibody to CCR5, blocks breast cancer cellular metastasis and enhances cell death induced by DNA damaging chemotherapy
por: Jiao, Xuanmao, et al.
Publicado: (2021)

1109. Pharmacokinetics and Exposure of Cefepime in Critically Ill Patients Receiving Extracorporeal Membrane Oxygenation (ECMO)
por: Kois, Abigail K, et al.
Publicado: (2021)

Cardiac arrest from massive PE in nephrotic syndrome successfully treated with embolectomy and ECMO
por: Connor-Schuler, Randi, et al.
Publicado: (2018)

A Case Series of Black and Hispanic COVID-19 Patients Treated with ECMO
por: Quesada, C. Tejera, et al.
Publicado: (2021)

OUTCOMES OF WHITE VS MINORITY PATIENTS WITH COVID-19 WITH ARDS TREATED WITH ECMO
por: REDDY, RENUKA, et al.
Publicado: (2021)

Cardiogenic Shock in COVID 19 Fulminant Myocarditis Treated with V-A ECMO
por: D'Errico Ramirez, A., et al.
Publicado: (2022)

REDUCED RV FUNCTION IS ASSOCIATED WITH MORTALITY IN COVID-19 PATIENTS TREATED WITH ECMO
por: Donthi, Nisha, et al.
Publicado: (2021)

BLOODSTREAM INFECTIONS IN PATIENTS WITH COVID-19 TREATED WITH EXTRACORPOREAL MEMBRANE OXYGENATION (ECMO)
por: SHARAYAH, AHMAD, et al.
Publicado: (2022)

Extracorporeal Membrane Oxygenation (ECMO) in Critically Ill Patients with Coronavirus Disease 2019 (COVID-19) Pneumonia and Acute Respiratory Distress Syndrome (ARDS)
por: Ma, Xiaochun, et al.
Publicado: (2020)

Successful approach for emergent consent for ECMO research
por: Board, J, et al.
Publicado: (2015)

When to initiate ECMO with low likelihood of success
por: MacLaren, Graeme
Publicado: (2018)

Reply to Supady et al. Comment on: Extracorporeal hemoadsorption in critically ill COVID-19 patients on VV ECMO: the CytoSorb therapy in COVID-19 (CTC) registry
por: Hayanga, J. W. Awori
Publicado: (2023)

COVID-19 ECMO Myths Busted
por: Sharma, Amita, et al.
Publicado: (2020)

ECMO for ARDS due to COVID-19
por: Ñamendys-Silva, Silvio A.
Publicado: (2020)

What’s new in ECMO for COVID-19?
por: MacLaren, Graeme, et al.
Publicado: (2020)

What is New in ECMO for COVID-19?
por: Furzan, Alberto, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_32vpv30139tsnqm0tr4cpra857